Based on the above results, we demonstrated that knock down of LncRNA-MCM3AP-AS1 inhibits the progression of hemangioma by decreasing glycolysis via regulating miR-138-5p/HIF-1α axis, which laid a foundation for exploring the molecular mechanism of IH treatment. The gene discussed is HIF1A; the disease is hemangioma.